Kevan C Herold

Yale University

Research Areas

• Diabetes and associated disorders
• Pancreatic function and diabetes
• Diabetes Management and Research
• Immune Cell Function and Interaction
• T-cell and B-cell Immunology

Papers (1)

• 2023
  A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.10.1007/s00125-023-06014-2